Repligen Corporation to Present at Upcoming Investor Conferences
WALTHAM, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be presenting at two upcoming investor conferences.
- WALTHAM, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be presenting at two upcoming investor conferences.
- Stifel 2023 Healthcare Conference being held November 14-15 in New York City.
- Hunt, Chief Executive Officer, will participate in an analyst-led discussion on Wednesday, November 15, at 8:00 a.m.
- Hunt, Chief Executive Officer, will participate in an analyst-led discussion on Thursday, November 16, at 11:00 a.m.